NL7107529A - - Google Patents

Info

Publication number
NL7107529A
NL7107529A NL7107529A NL7107529A NL7107529A NL 7107529 A NL7107529 A NL 7107529A NL 7107529 A NL7107529 A NL 7107529A NL 7107529 A NL7107529 A NL 7107529A NL 7107529 A NL7107529 A NL 7107529A
Authority
NL
Netherlands
Application number
NL7107529A
Other versions
NL177599C (nl
NL177599B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7107529A publication Critical patent/NL7107529A/xx
Publication of NL177599B publication Critical patent/NL177599B/xx
Application granted granted Critical
Publication of NL177599C publication Critical patent/NL177599C/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/76Albumins
    • C07K14/765Serum albumin, e.g. HSA
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14Extraction; Separation; Purification
    • C07K1/30Extraction; Separation; Purification by precipitation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NL7107529A 1970-06-02 1971-06-01 Werkwijze voor het winnen en zuiveren van immunoglobuline g. NL177599C (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE763270A SE348942B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1970-06-02 1970-06-02

Publications (3)

Publication Number Publication Date
NL7107529A true NL7107529A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1971-12-06
NL177599B NL177599B (nl) 1985-05-17
NL177599C NL177599C (nl) 1985-10-16

Family

ID=20271889

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7107529A NL177599C (nl) 1970-06-02 1971-06-01 Werkwijze voor het winnen en zuiveren van immunoglobuline g.

Country Status (8)

Country Link
AT (1) AT309678B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CA (1) CA960964A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH572745A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE2127159C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2100716B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB1344340A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL177599C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE (1) SE348942B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE389596B (sv) * 1974-06-14 1976-11-15 P G S Lindroos Saett att ur en vaetska innehallande blodsubstanser separera jaernfoereningar fran globin
DE2500076C3 (de) * 1975-01-02 1982-11-18 SCHURA Blutderivate GmbH & Co KG, 4150 Krefeld Verfahren zur Gewinnung von intravenös-verträglichen Gammaglobulinen
US4124576A (en) * 1976-12-03 1978-11-07 Coval M L Method of producing intravenously injectable gamma globulin
AT359641B (de) * 1978-09-19 1980-11-25 Immuno Ag Verfahren zur herstellung eines intravenoes ver- abreichbaren antikoerperhaeltigen immunglobulin- praeparates
US4315851A (en) 1978-12-29 1982-02-16 Kureha Kagaku Kogyo Kabushiki Kaisha Pharmaceutical composition having antitumor activity
CN102272146A (zh) * 2009-01-13 2011-12-07 通用电气健康护理生物科学股份公司 用带负电的聚合物沉淀生物分子
MY157239A (en) 2009-05-27 2016-05-13 Baxalta Inc A method to produce a highly concentrated immunoglobulin preparation for subcutaneous use
IT1397061B1 (it) * 2009-12-28 2012-12-28 Kedrion Spa Nuovo processo di purificazione su scala industriale di gammaglobuline da plasma umano per uso industriale.
US8796430B2 (en) 2010-05-26 2014-08-05 Baxter International Inc. Method to produce an immunoglobulin preparation with improved yield
US8772462B2 (en) 2010-05-26 2014-07-08 Baxter International Inc. Removal of serine proteases by treatment with finely divided silicon dioxide
AU2010202125B1 (en) 2010-05-26 2010-09-02 Takeda Pharmaceutical Company Limited A method to produce an immunoglobulin preparation with improved yield
ES2624485T3 (es) 2011-08-26 2017-07-14 Baxalta GmbH Método para reducir el potencial tromboembólico de una composición de inmunoglobulinas derivada de plasma
TWI629283B (zh) 2012-02-23 2018-07-11 巴克斯歐塔公司 來自血漿中的免疫球蛋白之i-iv-1部分沉澱
AU2013203088B2 (en) 2012-02-29 2015-12-03 Takeda Pharmaceutical Company Limited IgG stimulated remyelination of peripheral nerves
EP3597220A1 (en) 2013-02-26 2020-01-22 Baxalta GmbH Treatment of central nervous system disorders by intranasal administration of immunoglobulin g
EP3552624A1 (en) 2013-05-06 2019-10-16 Baxalta Incorporated Treatment of alzheimer's disease subpopulations with pooled immunoglobulin g
CN118891279A (zh) 2022-03-07 2024-11-01 武田药品工业株式会社 临床人IgG产品的亲和色谱生产

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL286954A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1962-01-03
BE713764A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) * 1967-05-01 1968-09-16 Baxter Travenol Lab
AT275038B (de) * 1967-11-15 1969-10-10 Immuno Ag Verfahren zur Gewinnung von reinem Blutalbumin aus Hämopigmente enthaltenden Proteinlösungen

Also Published As

Publication number Publication date
SE348942B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-09-18
FR2100716B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1975-06-06
FR2100716A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1972-03-24
DE2127159A1 (de) 1971-12-09
NL177599C (nl) 1985-10-16
CH572745A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1976-02-27
DE2127159C2 (de) 1981-12-24
NL177599B (nl) 1985-05-17
CA960964A (en) 1975-01-14
AT309678B (de) 1973-08-27
GB1344340A (en) 1974-01-23

Similar Documents

Publication Publication Date Title
AR204384A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR2100716B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ATA96471A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1146470A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU2044470A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU2130570A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1716970A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU2017870A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1833270A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU2085370A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1918570A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1343870A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1872870A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1879170A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1881070A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1086670A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1943370A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1591370A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU2144270A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU2131570A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU2130770A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU1969370A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU2119370A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU2115870A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU2112570A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
V4 Lapsed because of reaching the maxim lifetime of a patent